1. From: High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
Ann Intern Med. 2004;140(2): doi: /
Figure Legend:
Algorithm for patient selection and treatment with high-dose melphalan and stem-cell transplantation.
Date of download: 10/13/2017
Copyright © American College of Physicians. All rights reserved.

2. From: High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
Ann Intern Med. 2004;140(2): doi: /
Figure Legend:
Survival curve for all patients (top) and for patients with cardiac versus noncardiac involvement (bottom).P
Date of download: 10/13/2017
Copyright © American College of Physicians. All rights reserved.

3. From: High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
Ann Intern Med. 2004;140(2): doi: /
Figure Legend:
Survival curves according to hematologic response at 1 year from treatment.P
Date of download: 10/13/2017
Copyright © American College of Physicians. All rights reserved.